Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 657 out of 120,621 Researchers
Data For The Year: 2026
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152,116 | 160,634 |
| Total Cites | 673 | 727 |
| H-index | 12 | 13 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 250 | 262 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 406 | 443 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 607 | 635 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.14 |
| Self-Citation Percentage |
7.43%
|
|
Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 861 out of 112,089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 197,890 | 182,175 |
| Total Cites | 514 | 579 |
| H-index | 10 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 236 | 252 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 322 | 362 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 478 | 505 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.15 |
| Self-Citation Percentage |
11.23%
|
|
Xu, Haiyu
Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College,
China
2024 Rank: 280,868
Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,334 out of 105,998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 280,868 | 249,153 |
| Total Cites | 390 | 445 |
| H-index | 8 | 10 |
| Hm-index | 2 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 163 | 181 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 203 | 238 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 370 | 404 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.10 |
| Self-Citation Percentage |
12.36%
|
|
Overall Rank
Rank in SubField 1
Publications
Total Cites
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1,512 out of 94,672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 300,949 | 281,680 |
| Total Cites | 299 | 349 |
| H-index | 7 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 139 | 151 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 148 | 161 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 268 | 285 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.22 |
| Self-Citation Percentage |
14.33%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.